| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |